ADVANCED BREAST CANCER
Clinical trials for ADVANCED BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED BREAST CANCER trials appear
Sign up with your email to follow new studies for ADVANCED BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise in early trial for Hard-to-Treat breast cancer
Disease control TerminatedThis early-stage study tests a new oral drug, BBI-940, in people with advanced or metastatic breast cancer that has not responded to standard treatments. The drug works by breaking down a protein that helps cancer cells grow. The study aims to find the safest dose and check for s…
Matched conditions: ADVANCED BREAST CANCER
Phase: PHASE1 • Sponsor: Boundless Bio, Inc. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New drug combo for advanced breast cancer shows promise but trial halted early
Disease control TerminatedThis phase 2 study tested a new drug called lerociclib combined with standard hormone therapy in 100 people with advanced HR+/HER2- breast cancer. The goal was to see if the combination is safe and effective. However, the trial was terminated early, so the full results are not av…
Matched conditions: ADVANCED BREAST CANCER
Phase: PHASE2 • Sponsor: EQRx, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC